Evolent Health Inc
EVH
NYSE
Health Care
$3.95
USD
+0.36 (+10.03%)
At close: Aug 7, 2026, 4:00 PM EDT
Market Cap $453.86M
Volume 5.1M
About Evolent Health Inc
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 4,200 full-time employees. The company went IPO on 2015-06-05. The firm offers primary solutions, including specialty care management services and administrative services. The company provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
HQ
Arlington, VIRGINIA, US
Founded
2015
Employees
4,200
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
6 metrics our research team weighs before forming a view on EVH.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Revenue Growth (TTM)
-21.3%
-31.5 pp
Gross Margin (TTM)
20.2%
+4.9 pp
Operating Margin (TTM)
-23.0%
-21.8 pp
Net Margin (TTM)
-26.3%
-21.7 pp
ROE (TTM)
-125.3%
-113.6 pp
Free Cash Flow (TTM)
$1.11M
—
Financial Snapshot
Revenue
$1.89B
-21.3%
YoY
Gross Margin
20%
TTM
+32.4%
YoY
Net Income
$-496.52M
-355.7%
YoY
Operating Cash Flow
$33.01M
+20.8%
YoY
Key Statistics
Open
$3.70
Previous Close
$3.59
Day Range
$3.61 - $4.13
52 Week Range
$2.10 - $10.08
Volume
5.1M
Average Volume (10 Days)
4.8M
Dividend Yield
—
Valuation Measurement
Market Cap
$453.86M
P/E Ratio (TTM)
—
P/S Ratio (TTM)
0.24
Price / Book
1.14
Financial Highlights
Profit Margin
-26.3%
Return on Assets
-26.4%
Return on Equity
-125.3%
Revenue (TTM)
$1.89B
Net Income (TTM)
$-496.52M
Diluted EPS (TTM)
-$4.68
Total Cash (MRQ)
$142.03M
Levered FCF (TTM)
$1.11M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 04
Est. EPS
Adjusted consensus estimate
$0.06
Analyst Consensus
Based on 3 analyst ratings
Avg Target: $6.58
(+66.6% upside)
High: $7.00 · Low: $6.00
Strong Buy
0%
Buy
33%
Hold
67%
Sell
0%
Strong Sell
0%